These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25861161)

  • 1. Effect of oral and vaginal hormonal contraceptives on inflammatory blood biomarkers.
    Divani AA; Luo X; Datta YH; Flaherty JD; Panoskaltsis-Mortari A
    Mediators Inflamm; 2015; 2015():379501. PubMed ID: 25861161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral versus vaginal combined hormonal contraceptives' effect on coagulation and inflammatory biomarkers among young adult women.
    Divani AA; Luo X; Brandy KR; Meyer RM; Joseph MS; Flaherty JD; Rao GH; Datta YH
    Clin Appl Thromb Hemost; 2012 Sep; 18(5):487-94. PubMed ID: 22431858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of third-generation oral contraceptives on high-sensitivity C-reactive protein and homocysteine in young women.
    Cauci S; Di Santolo M; Culhane JF; Stel G; Gonano F; Guaschino S
    Obstet Gynecol; 2008 Apr; 111(4):857-64. PubMed ID: 18378744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended regimens of the contraceptive vaginal ring versus hormonal oral contraceptives: effects on lipid metabolism.
    Guazzelli CA; Barreiros FA; Barbosa R; Torloni MR; Barbieri M
    Contraception; 2012 Apr; 85(4):389-93. PubMed ID: 22067754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral, transdermal and vaginal combined contraceptives induce an increase in markers of chronic inflammation and impair insulin sensitivity in young healthy normal-weight women: a randomized study.
    Piltonen T; Puurunen J; Hedberg P; Ruokonen A; Mutt SJ; Herzig KH; Nissinen A; Morin-Papunen L; Tapanainen JS
    Hum Reprod; 2012 Oct; 27(10):3046-56. PubMed ID: 22811306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body weight and oral contraceptives are the most important modulators of serum CRP levels.
    Buchbinder S; Kratzsch J; Fiedler GM; Yar V; Brügel M; Leichtle A; Weber W; Alexander H; Matthes G; Thiery J
    Scand J Clin Lab Invest; 2008; 68(2):140-4. PubMed ID: 17852819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Masking effect of hormonal contraceptives on discriminating quantitative features of visually normal intermediate cells in positive and negative cervical smears.
    Kwikkel HJ; Boon ME; van Rijswijk MM; Rietveld WJ; Stolk JG
    Anal Quant Cytol Histol; 1986 Sep; 8(3):227-32. PubMed ID: 3778614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of body temperature, interleukin-6 and leptin by oral contraceptive use.
    Salkeld BD; MacAulay JC; Ball RW; Cannon JG
    Neuroimmunomodulation; 2001; 9(6):319-25. PubMed ID: 12045359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of combined oral contraceptives alters metabolic determinants and genetic regulation of C-reactive protein. The Cardiovascular Risk in Young Finns Study.
    Haarala A; Eklund C; Pessi T; Lehtimäki T; Huupponen R; Jula A; Viikari J; Raitakari O; Hurme M
    Scand J Clin Lab Invest; 2009; 69(2):168-74. PubMed ID: 18937150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between C-reactive protein, metabolic cardiovascular risk factors, obesity and oral contraceptive use in young adults.
    Williams MJ; Williams SM; Milne BJ; Hancox RJ; Poulton R
    Int J Obes Relat Metab Disord; 2004 Aug; 28(8):998-1003. PubMed ID: 15211365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose progestin-releasing contraceptives are associated with a higher pain threshold in healthy women.
    Máximo MM; Silva PS; Vieira CS; Gonçalvez TM; Rosa-E-Silva JC; Candido-Dos-Reis FJ; Nogueira AA; Poli-Neto OB
    Fertil Steril; 2015 Nov; 104(5):1182-9. PubMed ID: 26341277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the combined steroidal contraceptives (Gynanovlar 21 and Lyndiol 2.5) on the human adrenocortical and ovarian activities.
    Zaki K; Kamal I; Talaat MM; Rashad S; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):41-65. PubMed ID: 12256027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of synthetic progestagens on autonomic tone, neurohormones and C-reactive protein levels in young healthy females in reproductive age.
    Schueller PO; Feuring M; Sharkova Y; Grimm W; Christ M
    Int J Cardiol; 2006 Jul; 111(1):42-8. PubMed ID: 16083980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population.
    Morin-Papunen L; Martikainen H; McCarthy MI; Franks S; Sovio U; Hartikainen AL; Ruokonen A; Leinonen M; Laitinen J; Järvelin MR; Pouta A
    Am J Obstet Gynecol; 2008 Nov; 199(5):529.e1-529.e10. PubMed ID: 18533124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive association between 25-hydroxyvitamin D and C-reactive protein is confounded by hormonal contraceptive use.
    García-Bailo B; Josse AR; Jamnik J; Badawi A; El-Sohemy A
    J Womens Health (Larchmt); 2013 May; 22(5):417-25. PubMed ID: 23659482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid function, activated protein C resistance and the risk of venous thrombosis in users of hormonal contraceptives.
    Raps M; Curvers J; Helmerhorst FM; Ballieux BE; Rosing J; Thomassen S; Rosendaal FR; van Vliet HA
    Thromb Res; 2014 Apr; 133(4):640-4. PubMed ID: 24438944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin receptors in circulating erythrocytes and monocytes from women on oral contraceptives or pregnant women near term.
    Tsibris JC; Raynor LO; Buhi WC; Buggie J; Spellacy WN
    J Clin Endocrinol Metab; 1980 Oct; 51(4):711-7. PubMed ID: 6998996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in inflammation markers after a 10-week high-intensity combined strength and endurance training block in women: The effect of hormonal contraceptive use.
    Ihalainen JK; Hackney AC; Taipale RS
    J Sci Med Sport; 2019 Sep; 22(9):1044-1048. PubMed ID: 31186194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.